Sunshine Biopharma (SBFM) EPS (Basic) (2010 - 2026)
Sunshine Biopharma (SBFM) reported EPS (Basic) of -$0.25 for Q1 2026, up 43.18% on a YoY basis from -$0.17 in Q1 2025, and up 45.65% quarter-over-quarter from -$0.46 in Q4 2025.
Sunshine Biopharma (SBFM) EPS (Basic) (2010 - 2026) Analysis & Trends
Sunshine Biopharma has reported EPS (Basic) for 17 years, with the latest figure at -$0.25 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 43.18% year-over-year to -$0.25; the trailing twelve-month figure through Mar 2026 stood at -$1.29 (up 74.35% YoY), and the FY2025 full-year result was -$1.44, up 80.33% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.25, up from -$0.46 in the prior quarter.
- The five-year high for EPS (Basic) was $6.29 in Q4 2024, with the low at -$85.65 in Q4 2023.
- Historically, EPS (Basic) has averaged -$13.25 across 5 years, with a median of -$0.46 in 2025.
- Annual changes were most pronounced in 2023 — EPS (Basic) tumbled 237133.33% — and 2024, when it jumped 107.34%.
- Sunshine Biopharma's EPS (Basic) stood at -$1.55 in 2022, then plunged by 5430.04% to -$85.65 in 2023, then jumped by 107.34% to $6.29 in 2024, then sank by 107.31% to -$0.46 in 2025, then surged by 45.65% to -$0.25 in 2026.
- The last three EPS (Basic) figures came in at -$0.25 (Q1 2026), -$0.46 (Q4 2025), and -$0.19 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.32 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.32 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.97 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.83 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Sunshine Biopharma | 11.70 Mn | 4.79 Mn | 2.18 Mn | -0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.25 |
| Dec 31, 2025 | -0.46 |
| Sep 30, 2025 | -0.19 |
| Jun 30, 2025 | -0.39 |
| Mar 31, 2025 | -0.44 |
| Dec 31, 2024 | 6.29 |
| Sep 30, 2024 | -0.94 |
| Jun 30, 2024 | -9.94 |
| Mar 31, 2024 | -2.00 |
| Dec 31, 2023 | -85.65 |
| Sep 30, 2023 | -50.72 |
| Jun 30, 2023 | -71.17 |
| Mar 31, 2023 | -7.73 |
| Dec 31, 2022 | -1.55 |
| Sep 30, 2022 | 0.08 |
| Jun 30, 2022 | -0.03 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | 0.97 |
| Sep 30, 2021 | -1.59 |
| Jun 30, 2021 | -1.21 |